Mesothelioma

Overview and management.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 October 2025
RespiratoryOncology

Clinical Guidelines

British Thoracic Society Guideline for the investigation of management of mesothelioma
National
BTS Guideline for the investigation and management of malignant pleural mesothelioma
National
BTS Guideline for the investigation and management of pleural mesothelioma
National
CKS: Lung and pleural cancers - recognition and referral
National
ESMO Clinical Practice Guideline: Malignant Pleural Mesothelioma
National
NICE guideline [TA818]: Nivolumab with ipilimumab for untreated unresectable malignant pleural mesothelioma
National
Guidelines for Pathologic Diagnosis of Malignant Mesothelioma: 2012 Update of the Consensus Statement from the International Mesothelioma Interest Group
Local
Guidelines for Pathologic Diagnosis of Mesothelioma: 2023 Update of the Consensus Statement from the International Mesothelioma Interest Group
Local
Malignant Mesothelioma Treatment (PDQ®) – Health Professional Version
Local
Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Local
NCCN Clinical Practice Guidelines in Oncology: Mesothelioma (Pleural and Peritoneal)
Local
Peritoneal mesothelioma: PSOGI/EURACAN Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up
Local
Society for Immunotherapy of Cancer (SITC) Clinical Practice Guideline on Immunotherapy for the Treatment of Lung Cancer and Mesothelioma
Local
Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline
Local
Treatment of Pleural Mesothelioma: ASCO Guideline Update
Local